Skip to main content
logo
Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1090
-0.0035 (-3.11%)
Sep 4, 2026, 10:32 AM CET

Spago Nanomedical AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.814.476.665.642.512.23
Revenue Growth
-38.05%-32.85%17.95%124.87%12.61%60.29%
Gross Profit
-8.43-7.01-7.61-18.84-17.84-19.46
Operating Income
-26.27-26.48-33.38-42.51-39.09-39.07
Net Income
-26.28-26.55-32.51-42.22-39.2-39.07
Earnings Per Share
-0.05-0.07-0.11-0.43-0.61-0.99
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
32.5129.6732.4745.2262.152.46
Total Debt
------
Net Cash (Debt)
32.5129.6732.4745.2262.152.46
Net Cash Growth
75.56%-8.62%-28.19%-27.19%18.38%84.41%
Net Cash Per Share
0.060.080.090.460.971.33

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-25.12-28.3-34.67-44.91-38.19-35.57
Capital Expenditures
---0-0.15-0.13-0.37
Free Cash Flow
-25.12-28.3-34.67-45.06-38.32-35.94
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-221.30%-156.90%-114.41%---
Operating Margin
-689.89%-592.50%-501.56%-753.37%-1557.79%-1753.46%
Pretax Margin
-690.20%-594.18%-488.49%-748.37%-1562.26%-1753.64%
Profit Margin
-690.21%-594.18%-488.49%-748.37%-1562.26%-1753.64%
FCF Margin
-659.53%-633.18%-520.95%-798.69%-1527.34%-1613.20%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-1.901.901.903.6045.71
PS Ratio
23.5917.2510.2612.6522.8488.72